Research output per year
Research output per year
Personal profile
Research Biography
Dr Ross trained in clinical and laboratory haematology at the Royal Adelaide Hospital and Institute of Medical & Veterinary Science, spending one year at Addenbrooke's Hospital in Cambridge. In 2009 he was awarded a PhD for a thesis on the subject of minimal residual disease in chronic myeloid leukaemia.
In 2009 he joined the haematology department at Flinders Medical Centre, where he is responsible for diagnostic haematology services. He is an investigator in several clinical trials for haematological malignancies, and an active member of the Australasian Leukaemia & Lymphoma Group.
His areas of interest include myeloid malignancies and minimal residual disease.
Current projects include
- monitoring of treatment response in chronic myeloid leukaemia and acute promyelocytic leukaemia; and
- diagnosis of myeloproliferative neoplasms, such as polycythaemia rubra vera.
Fingerprint
Dive into the research topics where David Ross is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting
Lim, K., Kan, W. L., Nair, P. C., Kutyna, M., Lopez, A. F., Hercus, T., Ross, D. M., Lane, S., Fong, C. Y., Brown, A., Yong, A., Yeung, D., Hughes, T., Hiwase, D. & Thomas, D., Sept 2024, In: PLoS One. 19, 9, 19 p., e0310641.Research output: Contribution to journal › Article › peer-review
Open AccessFile8 Downloads (Pure) -
A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data
Sharplin, K., Proudman, W., Chhetri, R., Tran, E. N. H., Choong, J., Kutyna, M., Selby, P., Sapio, A., Friel, O., Khanna, S., Singhal, D., Damin, M., Ross, D., Yeung, D., Thomas, D., Kok, C. H. & Hiwase, D., 8 Aug 2023, In: Cancers. 15, 16, 14 p., 4019.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)51 Downloads (Pure) -
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
Irani, Y. D., Kok, C. H., Clarson, J., Shanmuganathan, N., Branford, S., Yeung, D. T., Ross, D. M., Hughes, T. P. & Yong, A. S. M., 13 Jun 2023, In: Blood Advances. 7, 11, p. 2364-2374 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Citations (Scopus)33 Downloads (Pure) -
Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
Alcheikh, A., Perkins, G. B., Pucar, P. A., Cecchin, A., Chai, C. S., Tunbridge, M., Akerman, A., Aggarwal, A., Milogiannakis, V., Turville, S., Allen, S., Hissaria, P., Banovic, T., Coates, P. T. & Ross, D. M., 10 Apr 2023, In: Blood Cancer Journal. 13, 1, 4 p., 50.Research output: Contribution to journal › Letter › peer-review
Open AccessFile2 Citations (Scopus)38 Downloads (Pure) -
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha
Irani, Y. D., Hughes, A., Kok, C. H., Clarson, J., Yeung, D. T., Ross, D. M., Branford, S., Hughes, T. P. & Yong, A. S. M., Sept 2023, In: British Journal of Haematology. 202, 6, p. 1127-1136 10 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)